LIQUENT, a Calyx Company Email Format
Software DevelopmentPennsylvania, United States51-200 Employees
Calyx, formerly Liquent, operates in software development with a focus on eClinical and regulatory solutions for clinical research. The company provides software-enabled services designed to address the complex data management and regulatory challenges that accompany clinical development and submissions. Positioned in the life sciences software sector, it serves sponsors and contract research organizations seeking to streamline data workflows and regulatory processes. Headquartered in Horsham, Pennsylvania, Calyx is a mid-sized firm within the pharmaceutical and biotech development ecosystem. The organization has rebranded from Liquent to Calyx, with current updates shared via its LinkedIn presence and calyx.ai. In March 2024, Calyx announced its acquisition of Invicro, a provider focused on quantitative imaging biomarkers for pharma sponsors, a move that broadens its capabilities in imaging data and trial analytics.